Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02.
J Neurooncol
; 136(1): 79-86, 2018 Jan.
Article
in En
| MEDLINE
| ID: mdl-28988377
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Brain Neoplasms
/
Glioblastoma
/
Quinolones
/
Sorafenib
/
Neoplasm Recurrence, Local
/
Antineoplastic Agents
Language:
En
Journal:
J Neurooncol
Year:
2018
Type:
Article
Affiliation country:
United States